<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) can induce a broad spectrum of <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e>, especially in immune deficient patients </plain></SENT>
<SENT sid="1" pm="."><plain>We assayed for receptor for EBV (EBVR) using fluoresceinated <z:mp ids='MP_0001799'>viral</z:mp> particles on 44 human hematopoietic cell lines derived from patients with T, B, and non-T, non-B <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ALL), non-<z:hpo ids='HP_0005526'>lymphoid leukemia</z:hpo>, Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:mp ids='MP_0009440'>myeloma</z:mp> and several unique lines we and others have recently developed </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 31 EBV nuclear-associated antigen (EBNA) negative cell lines were of neoplastic origin </plain></SENT>
<SENT sid="3" pm="."><plain>Seven of 13 EBNA-positive cell lines were of <z:mpath ids='MPATH_458'>normal</z:mpath> cell origin </plain></SENT>
<SENT sid="4" pm="."><plain>Four of 25 non-B (surface immunoglobulin negative) EBNA-negative neoplastic cell lines were EBVR-positive </plain></SENT>
<SENT sid="5" pm="."><plain>Three of six EBNA-negative B-cell (surface immunoglobulin positive) lines were EBVR-positive </plain></SENT>
<SENT sid="6" pm="."><plain>Nine of 13 EBNA-positive Burkitt and non-Burkitt cell lines strongly expressed EBVR </plain></SENT>
<SENT sid="7" pm="."><plain>Four EBNA-positive Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines exhibited EBVR only to a limited degree </plain></SENT>
<SENT sid="8" pm="."><plain>Studies of the cell lines for EBVR, complement receptors (CR) and surface immunoglobulin (SIg) revealed that presence of SIg does not obligate the presence of EBVR </plain></SENT>
<SENT sid="9" pm="."><plain>Functional EBVR accompanied SIg among EBNA-negative cell lines </plain></SENT>
<SENT sid="10" pm="."><plain>SIg-negative cell lines can possess EBVR </plain></SENT>
<SENT sid="11" pm="."><plain>Fourteen of 16 EBVR-positive lines were also positive for CR </plain></SENT>
<SENT sid="12" pm="."><plain>The EBVR assay is a useful tool for assessing the potential role of EBV in the induction of hematopoietic disorders </plain></SENT>
</text></document>